Calicheamicin
CAS No. 108212-75-5
Calicheamicin ( Calicheamicin γ1 )
Catalog No. M10324 CAS No. 108212-75-5
Calicheamicin γ1 is an enediyne antitumor antibiotic that acts by binding to DNA and causes strand scission; ADC payload used in development of antibody drug conjugates.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 515 | Get Quote |
|
10MG | 740 | Get Quote |
|
25MG | 1125 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCalicheamicin
-
NoteResearch use only, not for human use.
-
Brief DescriptionCalicheamicin γ1 is an enediyne antitumor antibiotic that acts by binding to DNA and causes strand scission; ADC payload used in development of antibody drug conjugates.
-
DescriptionCalicheamicin γ1 is an enediyne antitumor antibiotic that acts by binding to DNA and causes strand scission; ADC payload used in development of antibody drug conjugates.
-
SynonymsCalicheamicin γ1
-
PathwayAntibody Drug Conjugates (ADC)
-
TargetADC Cytotoxin
-
RecptorADC Cytotoxin
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number108212-75-5
-
Formula Weight1368.35
-
Molecular FormulaC55H74IN3O21S4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(S[C@@H]1[C@@H](C)O[C@@H](ON[C@@H]2[C@@H](C)OC(O[C@@H](C#C/C=C\C#C[C@@]3(O)C4)C(/C3=C\CSSSC)=C(NC(OC)=O)C4=O)[C@H](O[C@H]5C[C@H](OC)[C@@H](NCC)CO5)[C@H]2O)C[C@@H]1O)C6=C(OC)C(OC)=C(O[C@H]7[C@H](O)[C@H](OC)[C@@H](O)[C@H](C)O7)C(I)=C6C
-
Chemical NameCarbamic acid, N-[(1R,4Z,8S,13E)-8-[[4,6-dideoxy-4-[[[2,6-dideoxy-4-S-[4-[(6-deoxy-3-O-methyl-α-L-mannopyranosyl)oxy]-3-iodo-5,6-dimethoxy-2-methylbenzoyl]-4-thio-β-D-ribo-hexopyranosyl]oxy]amino]-2-O-[2,4-dideoxy-4-(ethylamino)-3-O-methyl-α-L-threo-pento
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lambert JM, et al. Adv Ther. 2017 May;34(5):1015-1035.
2. Guffroy M, et al. Clin Cancer Res. 2017 Apr 1;23(7):1760-1770.
3. Damelin M, et al. Clin Cancer Res. 2015 Sep 15;21(18):4165-73.
2. Guffroy M, et al. Clin Cancer Res. 2017 Apr 1;23(7):1760-1770.
3. Damelin M, et al. Clin Cancer Res. 2015 Sep 15;21(18):4165-73.
molnova catalog
related products
-
D211
A novel potent DNA-intercalating payload dimer (PBD dimer) payload for antibody-drug conjugates (ADCs); displays picomolar potency against AML cancer cell lines.
-
SG3199
SG3199 (SG-3199) is a PBD dimer warhead component of antibody-drug conjugate (ADC) payload tesirine, demonstrates potently cytotoxic against a panel of human solid tumour and haematological cancer cell lines with mean GI50 of 151.5 pM.
-
Daun02
Daun02 a prodrug that is converted by β-galactosidase to Daunorubicin, inactivate activated neurons that express both β-galactosidase and Fos.